Presurgical Treatment in HER2-Positive Breast Cancer Achieves Significant Reduction in Disease

Treatment with the HER2-targeted drugs lapatinib and trastuzumab before surgery and chemotherapy led to significant shrinkage or disappearance of the tumors in approximately one-quarter of women with HER2-positive breast cancer. These findings were presented at the 10th European Breast Cancer Conference.

 Oncology Nurse Advisor